| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Ignelzi Troy A. is a Chief Financial Officer at Rapport Therapeutics, Inc.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $381K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | RAPP Rapport Therapeutics, Inc. | Chief Financial Officer | Buy | 10,000 | $10.10 | $100,988.00 | +101.0% | +20.8% | +177.8% |